• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • Subscribe newsletter
  • Search
  • Menu Menu
International Hospital
  • AI
  • Cardiology
  • Oncology
  • Neurology
  • Genetics
  • Orthopaedics
  • Research
  • Surgery
  • Innovation
  • Medical Imaging
  • MedTech
  • Obs-Gyn
  • Paediatrics

Archive for category: E-News

E-News

gadoquatrane

Bayer submits low-dose gadolinium contrast agent for FDA approval

FDA, gadoquatrane, MRI, 17 June 2025/in E-News, Imaging /by panglobal

Bayer has submitted a New Drug Application to the US Food and Drug Administration for gadoquatrane, its investigational low-dose gadolinium-based contrast agent (GBCA) for contrast-enhanced magnetic resonance imaging of the central nervous system and other body regions. The submission covers use in adults and paediatric patients, including term neonates.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/06/gadoquatrane.jpg 958 1034 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-06-17 14:36:292025-06-17 14:36:29Bayer submits low-dose gadolinium contrast agent for FDA approval
mystical patient encounters

Sacred connections: How meaningful patient encounters are rescuing exhausted physicians

burnout, 2 June 2025/in E-News, Mental health, Research /by panglobal

A landmark survey in the United States has revealed that deeply meaningful patient encounters, termed “sacred moments,” could offer a powerful antidote to the epidemic of physician burnout plaguing healthcare systems worldwide.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/08/parkinsons_disease.jpg 572 1143 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-06-02 07:00:152025-05-30 12:00:33Sacred connections: How meaningful patient encounters are rescuing exhausted physicians
Journal of Neuro Trauma

New brain injury framework replaces outdated classification system, transforms diagnosis and treatment

brain injury, neuro trauma, 30 May 2025/in E-News, Neurology /by panglobal

A revolutionary multidimensional framework for characterising acute traumatic brain injury is set to replace the outdated Glasgow Coma Scale-based classification system. The new Clinical, Biomarker, Imaging-Modifiers (CBI-M) approach integrates blood biomarkers, advanced neuroimaging, and patient-specific factors to provide clinicians with unprecedented diagnostic precision for the first 24 hours post-injury.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/05/Journal-of-Neuro-Trauma.jpg 1294 1000 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-05-30 11:44:562025-05-30 11:44:56New brain injury framework replaces outdated classification system, transforms diagnosis and treatment
callan emery / Midjourney

Breakthrough in vivo gene therapy targets newborn blood stem cells

blood stem cells, 28 May 2025/in E-News, Genetics, Research /by panglobal

Scientists at the San Raffaele Telethon Institute for Gene Therapy have unlocked a remarkable biological window – a fleeting period immediately after birth when circulating blood stem cells become uniquely accessible for genetic modification directly within the body. This discovery could transform treatment approaches for devastating genetic blood disorders, offering hope without the invasive procedures […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/05/gene.png 700 700 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-05-28 15:14:212025-05-28 15:14:21Breakthrough in vivo gene therapy targets newborn blood stem cells
increased social media use during early adolescence directly contributes to elevated depressive symptomsCallan Emery / Midjourney

Major study exposes social media’s toxic impact on child mental health

adolescents, depression, social media, 28 May 2025/in E-News, Mental health /by panglobal

A comprehensive longitudinal study tracking nearly 12,000 American children has revealed compelling evidence that increased social media use during early adolescence directly contributes to elevated depressive symptoms, rather than simply reflecting pre-existing mental health challenges. The research provides the first robust scientific foundation for clinical recommendations regarding youth digital media consumption.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/05/kids_on_social_media.jpg 1000 1000 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-05-28 07:00:222025-05-26 14:41:26Major study exposes social media’s toxic impact on child mental health
ransomware healthcare data breaches

Ransomware emerges as primary driver of healthcare data breaches

cybersecurity, ransomware, 27 May 2025/in E-News, Health data /by panglobal

A comprehensive 15-year analysis reveals ransomware attacks have become the dominant force behind healthcare data breaches in the United States, compromising 285 million patient records and fundamentally reshaping the cybersecurity threat landscape for medical institutions in the US.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/05/data_hackers.jpg 1000 1000 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-05-27 08:00:502025-05-26 14:31:40Ransomware emerges as primary driver of healthcare data breaches
Hypertension breakthrough

Hypertension breakthrough: Controlling just 4 of 8 risk factors can eliminate early mortality danger

, 26 May 2025/in E-News, Hypertension /by panglobal

A comprehensive study involving nearly 300,000 participants reveals that controlling multiple cardiovascular risk factors simultaneously can eliminate the excess mortality risk associated with hypertension, offering new hope for preventive medicine strategies.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/05/Blood_pressure.jpg 605 1024 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-05-26 14:16:092025-05-26 14:16:09Hypertension breakthrough: Controlling just 4 of 8 risk factors can eliminate early mortality danger
The conclusion of discussions on the Pandemic Agreement in Committee at the World Health Assembly 2025.WHO / Chris Black

WHO adopts historic Pandemic Agreement to strengthen global health security

pandemic, public health, 21 May 2025/in E-News /by panglobal

The World Health Assembly has formally adopted the first-ever Pandemic Agreement after three years of negotiations, establishing a framework for equitable pandemic prevention, preparedness and response.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/05/who-pandemic-agreement.jpg 782 2540 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-05-21 14:46:552025-05-21 14:46:55WHO adopts historic Pandemic Agreement to strengthen global health security

Contactless atrial fibrillation detection system achieves clinical-grade accuracy

AI, atrial fibrillation, 20 May 2025/in Cardiology, Cardiovascular Disease, E-News /by panglobal

A groundbreaking contactless detection system for atrial fibrillation using radio technology and artificial intelligence has demonstrated clinical-grade diagnostic accuracy. Published in Nature Communications, the innovative system records heart mechanical motion via radar sensing and analyses it using neural networks, enabling detection without physical contact and potentially facilitating early diagnosis before symptoms appear.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/05/Afib_Diagram.jpg 1326 2300 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-05-20 18:00:472025-05-19 09:05:36Contactless atrial fibrillation detection system achieves clinical-grade accuracy
Inderbir Gill, MD (L) and Nima Nassiri, MD (C) perform the world’s first-in-human bladder transplant.

Medical milestone: World’s first human bladder transplant successfully performed

, 19 May 2025/in E-News, Surgery /by panglobal

A surgical team from USC and UCLA has made medical history by performing the world’s first human bladder transplant, opening a new frontier in transplantation medicine. The groundbreaking procedure, completed on May 4, 2025, at Ronald Reagan UCLA Medical Center, represents a culmination of years of research and surgical innovation.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/05/bladder_transplant.jpg 467 700 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-05-19 08:53:262025-05-19 08:53:26Medical milestone: World’s first human bladder transplant successfully performed
Page 2 of 231‹1234›»

Latest issue of International Hospital

April 2024

1 July 2025

BMJ investigation reveals AstraZeneca’s billion-dollar heart drug built on flawed data

27 June 2025

Scientists launch world first project to create synthetic human genome with £10mn Wellcome funding

27 June 2025

GE HealthCare advances precision imaging with MIM Encore platform

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign in for our newsletter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Media kit
    • Submit Press Release

Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Sign in for our newsletter

Free subscription